Skip to main content
. 2006 May 2;62(2):187–195. doi: 10.1111/j.1365-2125.2006.02628.x

Table 1.

Demographic data for study subjects

Variable Male Female
N 10 10
Age (years) 34.8 ± 7.9 38.2 ± 9.3
Total body weight (kg) 76.3 ± 13.3 79.5 ± 20.1
Ideal body weight (kg) 74.0 ± 6.8 kg 58.5 ± 6.3*
Midazolam dose (mg) 1.9 ± 0.3 2.0 ± 0.5
Aspartate aminotransferase (U l−1) 24.2 ± 4.8 24.0 ± 7.4
Alanine aminotransferase (U l−1) 30.1 ± 8.3 24.6 ± 9.2
Creatinine clearance (ml min−1 1–1.73 m2) 99.4 ± 14.7 81.3 ± 19.7*
Length of menstrual cycle (days) 27.2 ± 2.3
Follicular phase study day 5.6 ± 1.4
Luteal phase study day 18.3 ± 3.3

Data are given as mean±SD.

*

P < 0.05 compared with men.

Creatinine clearance was calculated using the Cockcroft and Gault method.